Abstract:Background Autoinflammatory diseases are inherited disorders of the innate immune system caused by aberrant activation of the innate immune cells, primarily neutrophils and macrophages. Genetic studies have led to the identification of mutations in 12 genes responsible for various monogenic autoinflammatory diseases, however a significant number of mutation negative patients are sporadic cases or come from small families underpowered for linkage analysis. Objectives To identify disease causing mutation in a family with dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, pulmonary disease, arthralgia, inflammatory eye, bowel disease, absence of autoantibodies, and mild immunodeficiency manifested by recurrent sino-pulmonary infections. Methods Whole-exome sequencing was performed on three samples, including the affected father and daughter and unaffected mother. Exome data were filtered in more than 6000 exomes to exclude reported variants along with benign variants as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. Results We confirmed a novel variant, p. S707Y, within the PLCG2 gene as the only de novo variant that was present in two affected and not present in four unaffected family members. PLCG2 encodes phospholipase Cγ2 (PLCγ2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The S707Y mutation is located in an autoinhibitory SH2 domain that is crucial for PLCγ2 activation. In vitro overexpression of the mutant S707Y protein and ex vivo experiments using patients’ leucocytes showed clearly enhanced PLCγ2 activity suggesting an increased intracellular signaling in the PLCγ2-mediated signaling pathway. Our finding that p. S707Y is hypermorphic mutation in PLCγ2 is further corroborated by animal studies that have implicated the critical role for PLCg2 in regulation of inflammation in mice. Two missense gain-of-function mutations in the murine phospholipase Cg2 (Plcg2) gene introduced by ENU mutagenesis, ALI5 and ALI14, lead to severe spontaneous inflammation and autoimmunity. Conclusions Recently, PLCG2 exon skipping mutations were reported in PLAID patients who present with cold-induced urticaria and immune dysregulation resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperature (ref). In contrast, we report here a missense PLCG2 mutation as a cause of a distinct inflammatory disease not provoked by cold temperatures, with different end-organ involvement and different cellular phenotype. Our result highlights the utility of exome sequencing technology in finding causal genes in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis. References Ombrello, M.J., Remmers, E.F., Sun, G., Freeman, A.F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T.D., Baxendale, R.W., Martins, M.S., et al. Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. N Engl J Med. Disclosure of Interest None Declared

Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

OP0174 Exome Sequencing Identifies a Hypermorphic Missense Mutation in the PLCG2 Gene As the Cause of a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency.

PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants

Splice site and de novo mutations can cause mixed dominant negative/gain of function PLCG2-associated immune dysregulation with cold urticaria (CU-PLAID)

A gain-of-function variation in PLCG1 causes a new immune dysregulation disease

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction

Loss of human ICOSL results in combined immunodeficiency.

DOCK2-deficiency causes defects in anti-viral T cell responses and impaired control of herpes simplex virus infection

Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity

Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance

Mutations in PLCG1 Is a Frequent Event in Cutaneous T-Cell Lymphomas

A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity

Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant

Novel and recurrent PHGDH and PSAT1 mutations in Chinese patients with Neu-Laxova syndrome

267 Defining the single-cell transcriptomes of splenic adaptive Natural Killer cells in donors with latent human cytomegalovirus infection